Insider Transactions in Q4 2023 at Amylyx Pharmaceuticals, Inc. (AMLX)
Insider Transaction List (Q4 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2023
|
Margaret Olinger Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+8.3%
|
$0
$0.37 P/Share
|
|
Dec 15
2023
|
Karen Firestone |
BUY
Open market or private purchase
|
Direct |
4,000
+44.44%
|
$56,000
$14.97 P/Share
|
|
Nov 27
2023
|
Camille L Bedrosian Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
58,333
+50.0%
|
-
|
|
Nov 16
2023
|
Joshua B Cohen Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
63,694
+2.14%
|
$63,694
$1.57 P/Share
|
|
Oct 31
2023
|
James M Frates Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
11,072
+50.0%
|
-
|